Aerovate Therapeutics Inc.
13F holders, Q2 2025 (June 30)2holders −80
0new positions
81sold out
$2.68avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Aerovate Therapeutics Inc. in their 13F filings, down 80 from Q1 2025. 0 opened new positions and 81 sold out. The largest holders were NorthCoast Asset Management LLC ($65K) and Alamea Verwaltungs GmbH ($512).
- Company
- Aerovate Therapeutics Inc.
- CUSIP
- 008064107
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 81 | $79.5M |
All 13F filers, Q1 2025 → Q2 2025: 31,674,289 shares sold, net −31,674,289 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| NorthCoast Asset Management LLC | 0.00% | Reduce -8.7% | 24,210 | $65K |
| Alamea Verwaltungs GmbH | 0.00% | No change | 204 | $512 |
"% of holder's portfolio" is AEROVATE THERAPEUTICS INC's weight in each manager's 13F, not the share of Aerovate Therapeutics Inc. the manager owns.